HB 3409: Allows insurers offering policies or certificates of health insurance and pharmacy benefit managers to require that a claim for reimbursement of a prescription drug include a modifier or other indicator that the drug is a 340B drug unless certain requirements are met.

Public testimony analysis — 4 testimonies submitted

Testimony Sentiment

1

Support

3

Oppose

0

Neutral

Organizational Positions2 organizations

Individual Testimony by Location2 locations

LocationTotalSupportOppose
Johnson and Johnson101
PhRMA101